These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Ethics and Global Governance of Human Germline Genome Editing: The Problem of Techno-Scientific Colonialist Paternalism. Arguedas-Ramírez G CRISPR J; 2020 Apr; 3(2):83-88. PubMed ID: 32315224 [TBL] [Abstract][Full Text] [Related]
7. CRISPR-Cas in Medicinal Chemistry: Applications and Regulatory Concerns. Duardo-Sanchez A Curr Top Med Chem; 2017; 17(30):3308-3315. PubMed ID: 29231142 [TBL] [Abstract][Full Text] [Related]
8. What Is Prudent Governance of Human Genome Editing? Schweikart SJ AMA J Ethics; 2019 Dec; 21(12):E1042-1048. PubMed ID: 31876467 [TBL] [Abstract][Full Text] [Related]
9. FDA Regulation of Clinical Applications of CRISPR-CAS Gene-Editing Technology. Grant EV Food Drug Law J; 2016; 71(4):608-33. PubMed ID: 29140647 [TBL] [Abstract][Full Text] [Related]
10. The Hope and Hype of CRISPR-Cas9 Genome Editing: A Review. Musunuru K JAMA Cardiol; 2017 Aug; 2(8):914-919. PubMed ID: 28614576 [TBL] [Abstract][Full Text] [Related]
11. A Crispr Future for Gene-Editing Regulation: a Proposal for an Updated Biotechnology Regulatory System in an Era of Human Genomic Editing. Tomlinson T Fordham Law Rev; 2018 Oct; 87(1):437-83. PubMed ID: 30296034 [TBL] [Abstract][Full Text] [Related]
12. Legal issues regarding gene editing at the beginning of life: an EU perspective. De Miguel Beriain I Regen Med; 2017 Sep; 12(6):669-679. PubMed ID: 28976851 [TBL] [Abstract][Full Text] [Related]
13. The trust game: CRISPR for human germline editing unsettles scientists and society. Braun M; Meacham D EMBO Rep; 2019 Feb; 20(2):. PubMed ID: 30602586 [TBL] [Abstract][Full Text] [Related]
15. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research]. Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746 [TBL] [Abstract][Full Text] [Related]
16. Why Include the Public in Genome Editing Governance Deliberation? Blasimme A AMA J Ethics; 2019 Dec; 21(12):E1065-1070. PubMed ID: 31876471 [TBL] [Abstract][Full Text] [Related]
17. CRISPR-Cas9 system: A new-fangled dawn in gene editing. Gupta D; Bhattacharjee O; Mandal D; Sen MK; Dey D; Dasgupta A; Kazi TA; Gupta R; Sinharoy S; Acharya K; Chattopadhyay D; Ravichandiran V; Roy S; Ghosh D Life Sci; 2019 Sep; 232():116636. PubMed ID: 31295471 [TBL] [Abstract][Full Text] [Related]
18. Human Genome Editing and Ethical Considerations. Krishan K; Kanchan T; Singh B Sci Eng Ethics; 2016 Apr; 22(2):597-9. PubMed ID: 26154417 [TBL] [Abstract][Full Text] [Related]
19. Experiments that led to the first gene-edited babies: the ethical failings and the urgent need for better governance. Li JR; Walker S; Nie JB; Zhang XQ J Zhejiang Univ Sci B; 2019 Jan.; 20(1):32-38. PubMed ID: 30614228 [TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas Genome Editing and Precision Plant Breeding in Agriculture. Chen K; Wang Y; Zhang R; Zhang H; Gao C Annu Rev Plant Biol; 2019 Apr; 70():667-697. PubMed ID: 30835493 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]